Gabapentin inhibits catecholamine release from adrenal chromaffin cells

Robert D. Todd, Sarah M. McDavid, Rebecca L. Brindley, Mark L. Jewell, Kevin P.M. Currie

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Gabapentin is most commonly prescribed for chronic pain, but acute perioperative effects, including preemptive analgesia and hemodynamic stabilization, have been reported. Adrenal chromaffin cells are a widely used model to investigate neurosecretion, and adrenal catecholamines play important physiologic roles and contribute to the acute stress response. However, the effects of gabapentin on adrenal catecholamine release have never been tested. Methods: Primary cultures of bovine adrenal chromaffin cells were treated with gabapentin or vehicle for 18-24 h. The authors quantified catecholamine secretion from dishes of cells using high-performance liquid chromatography and resolved exocytosis of individual secretory vesicles from single cells using carbon fiber amperometry. Voltage-gated calcium channel currents were recorded using patch clamp electrophysiology and intracellular [Ca 2+] using fluorescent imaging. Results: Gabapentin produced statistically significant reductions in catecholamine secretion evoked by cholinergic agonists (24 ± 3%, n = 12) or KCl (16 ± 4%, n = 8) (mean ± SEM) but did not inhibit Ca 2+ entry or calcium channel currents. Amperometry (n = 51 cells) revealed that gabapentin inhibited the number of vesicles released upon stimulation, with no change in quantal size or kinetics of these unitary events. Conclusions: The authors show Ca 2+ entry was not inhibited by gabapentin but was less effective at triggering vesicle fusion. The work also demonstrates that chromaffin cells are a useful model for additional investigation of the cellular mechanism(s) by which gabapentin controls neurosecretion. In addition, it identifies altered adrenal catecholamine release as a potential contributor to some of the beneficial perioperative effects of gabapentin.

Original languageEnglish (US)
Pages (from-to)1013-1024
Number of pages12
JournalAnesthesiology
Volume116
Issue number5
DOIs
StatePublished - May 1 2012

Fingerprint

Chromaffin Cells
Catecholamines
Neurosecretion
Calcium Channels
Cholinergic Agonists
gabapentin
Electrophysiology
Exocytosis
Secretory Vesicles
Chronic Pain
Analgesia
Hemodynamics
High Pressure Liquid Chromatography

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

Todd, Robert D. ; McDavid, Sarah M. ; Brindley, Rebecca L. ; Jewell, Mark L. ; Currie, Kevin P.M. / Gabapentin inhibits catecholamine release from adrenal chromaffin cells. In: Anesthesiology. 2012 ; Vol. 116, No. 5. pp. 1013-1024.
@article{38109f41e4a243e3b6b96f6944f9f14b,
title = "Gabapentin inhibits catecholamine release from adrenal chromaffin cells",
abstract = "Background: Gabapentin is most commonly prescribed for chronic pain, but acute perioperative effects, including preemptive analgesia and hemodynamic stabilization, have been reported. Adrenal chromaffin cells are a widely used model to investigate neurosecretion, and adrenal catecholamines play important physiologic roles and contribute to the acute stress response. However, the effects of gabapentin on adrenal catecholamine release have never been tested. Methods: Primary cultures of bovine adrenal chromaffin cells were treated with gabapentin or vehicle for 18-24 h. The authors quantified catecholamine secretion from dishes of cells using high-performance liquid chromatography and resolved exocytosis of individual secretory vesicles from single cells using carbon fiber amperometry. Voltage-gated calcium channel currents were recorded using patch clamp electrophysiology and intracellular [Ca 2+] using fluorescent imaging. Results: Gabapentin produced statistically significant reductions in catecholamine secretion evoked by cholinergic agonists (24 ± 3{\%}, n = 12) or KCl (16 ± 4{\%}, n = 8) (mean ± SEM) but did not inhibit Ca 2+ entry or calcium channel currents. Amperometry (n = 51 cells) revealed that gabapentin inhibited the number of vesicles released upon stimulation, with no change in quantal size or kinetics of these unitary events. Conclusions: The authors show Ca 2+ entry was not inhibited by gabapentin but was less effective at triggering vesicle fusion. The work also demonstrates that chromaffin cells are a useful model for additional investigation of the cellular mechanism(s) by which gabapentin controls neurosecretion. In addition, it identifies altered adrenal catecholamine release as a potential contributor to some of the beneficial perioperative effects of gabapentin.",
author = "Todd, {Robert D.} and McDavid, {Sarah M.} and Brindley, {Rebecca L.} and Jewell, {Mark L.} and Currie, {Kevin P.M.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1097/ALN.0b013e31825153ea",
language = "English (US)",
volume = "116",
pages = "1013--1024",
journal = "Anesthesiology",
issn = "0003-3022",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

Gabapentin inhibits catecholamine release from adrenal chromaffin cells. / Todd, Robert D.; McDavid, Sarah M.; Brindley, Rebecca L.; Jewell, Mark L.; Currie, Kevin P.M.

In: Anesthesiology, Vol. 116, No. 5, 01.05.2012, p. 1013-1024.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Gabapentin inhibits catecholamine release from adrenal chromaffin cells

AU - Todd, Robert D.

AU - McDavid, Sarah M.

AU - Brindley, Rebecca L.

AU - Jewell, Mark L.

AU - Currie, Kevin P.M.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Background: Gabapentin is most commonly prescribed for chronic pain, but acute perioperative effects, including preemptive analgesia and hemodynamic stabilization, have been reported. Adrenal chromaffin cells are a widely used model to investigate neurosecretion, and adrenal catecholamines play important physiologic roles and contribute to the acute stress response. However, the effects of gabapentin on adrenal catecholamine release have never been tested. Methods: Primary cultures of bovine adrenal chromaffin cells were treated with gabapentin or vehicle for 18-24 h. The authors quantified catecholamine secretion from dishes of cells using high-performance liquid chromatography and resolved exocytosis of individual secretory vesicles from single cells using carbon fiber amperometry. Voltage-gated calcium channel currents were recorded using patch clamp electrophysiology and intracellular [Ca 2+] using fluorescent imaging. Results: Gabapentin produced statistically significant reductions in catecholamine secretion evoked by cholinergic agonists (24 ± 3%, n = 12) or KCl (16 ± 4%, n = 8) (mean ± SEM) but did not inhibit Ca 2+ entry or calcium channel currents. Amperometry (n = 51 cells) revealed that gabapentin inhibited the number of vesicles released upon stimulation, with no change in quantal size or kinetics of these unitary events. Conclusions: The authors show Ca 2+ entry was not inhibited by gabapentin but was less effective at triggering vesicle fusion. The work also demonstrates that chromaffin cells are a useful model for additional investigation of the cellular mechanism(s) by which gabapentin controls neurosecretion. In addition, it identifies altered adrenal catecholamine release as a potential contributor to some of the beneficial perioperative effects of gabapentin.

AB - Background: Gabapentin is most commonly prescribed for chronic pain, but acute perioperative effects, including preemptive analgesia and hemodynamic stabilization, have been reported. Adrenal chromaffin cells are a widely used model to investigate neurosecretion, and adrenal catecholamines play important physiologic roles and contribute to the acute stress response. However, the effects of gabapentin on adrenal catecholamine release have never been tested. Methods: Primary cultures of bovine adrenal chromaffin cells were treated with gabapentin or vehicle for 18-24 h. The authors quantified catecholamine secretion from dishes of cells using high-performance liquid chromatography and resolved exocytosis of individual secretory vesicles from single cells using carbon fiber amperometry. Voltage-gated calcium channel currents were recorded using patch clamp electrophysiology and intracellular [Ca 2+] using fluorescent imaging. Results: Gabapentin produced statistically significant reductions in catecholamine secretion evoked by cholinergic agonists (24 ± 3%, n = 12) or KCl (16 ± 4%, n = 8) (mean ± SEM) but did not inhibit Ca 2+ entry or calcium channel currents. Amperometry (n = 51 cells) revealed that gabapentin inhibited the number of vesicles released upon stimulation, with no change in quantal size or kinetics of these unitary events. Conclusions: The authors show Ca 2+ entry was not inhibited by gabapentin but was less effective at triggering vesicle fusion. The work also demonstrates that chromaffin cells are a useful model for additional investigation of the cellular mechanism(s) by which gabapentin controls neurosecretion. In addition, it identifies altered adrenal catecholamine release as a potential contributor to some of the beneficial perioperative effects of gabapentin.

UR - http://www.scopus.com/inward/record.url?scp=84860775897&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860775897&partnerID=8YFLogxK

U2 - 10.1097/ALN.0b013e31825153ea

DO - 10.1097/ALN.0b013e31825153ea

M3 - Article

C2 - 22417967

AN - SCOPUS:84860775897

VL - 116

SP - 1013

EP - 1024

JO - Anesthesiology

JF - Anesthesiology

SN - 0003-3022

IS - 5

ER -